Academic Journal
Quantifying the economic effects of ravulizumab versus eculizumab treatment in patients with atypical hemolytic uremic syndrome
| العنوان: | Quantifying the economic effects of ravulizumab versus eculizumab treatment in patients with atypical hemolytic uremic syndrome |
|---|---|
| المؤلفون: | Levy, Adrian R., Chen, Peter, Johnston, Karissa, Wang, Yan, Popoff, Evan, Tomazos, Ioannis |
| المساهمون: | Alexion, AstraZeneca Rare Disease |
| المصدر: | Journal of Medical Economics ; volume 25, issue 1, page 249-259 ; ISSN 1369-6998 1941-837X |
| بيانات النشر: | Informa UK Limited |
| سنة النشر: | 2022 |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1080/13696998.2022.2027706 |
| الاتاحة: | http://dx.doi.org/10.1080/13696998.2022.2027706 https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2027706 |
| Rights: | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: | edsbas.A46D2221 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1080/13696998.2022.2027706 |
|---|